Corcept is leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators.
In 2012, we received FDA approval of Korlym® (mifepristone), the first approved treatment for hypercortisolism (Cushing’s syndrome).
Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation.
What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease.
Building on the success of the ROSELLA phase 3 clinical trial, the Corcept Oncology Clinical Development Team is growing. The Medical Director/Senior Medical Director, Oncology will act as a key participant in the design, execution and regulatory filing of oncology programs. They will ensure the good clinical conduct and scientific integrity of oncology clinical trials.

PREFERRED SKILLS, QUALIFICATIONS AND TECHNICAL PROFICIENCIES:

• Candidates must be excellent communicators with proven leadership skills and the ability to successfully interact in a busy cross functional environment
• Ability to establish and maintain a team “sense of urgency” around timelines

PREFERRED EDUCATION AND EXPERIENCE:

• MD required
• Board eligible or certified in an internal medicine subspecialty required; oncology / hematology board certification/eligibility preferred
• 2+ years’ clinical development experience in the biotechnology / pharmaceutical industry or an academic clinical trial unit
• A proven track record of scholarly clinical research demonstrated by publications in top tier journals
  The pay range that the Company reasonably expects to pay for this headquarters-based position is $290,000 - $377,000; the pay ultimately offered may vary based on legitimate considerations, including geographic location, job-related knowledge, skills, experience, and education.
  Applicants must be currently authorized to work in the United States on a full-time basis.
  For information on how Corcept collects, uses, discloses, protects, and otherwise processes personal information and an explanation of the rights and choices available to you with respect to your personal information, please refer to our Privacy Notice link.
  Corcept appreciates the commitment and hard work of all our team members as we strive to discover and develop novel treatments for patients with serious unmet medical needs.
  Please visit our website at: https://www.corcept.com/

• Design, develop, and implement clinical studies for the applicable drug candidate, from Phase I through Phase III
• Contribute to the clinical development plan for indications relevant to assigned molecule programs and support the assessment of the development plans through the cross-functional product core team
• Provide medical oversight for the company’s operational staff, CROs, and clinical trial sites in areas related to the oncology programs
• Provide medical monitoring oversight and safety monitoring for ongoing clinical trials including participation in SAE reporting and serving on the safety committee
• Deliver timely and high-quality clinical data
• Establish relationships with external experts in the scientific oncology areas, including principal investigators and opinion leaders, to facilitate scientific excellence in clinical trial research
• Participate in appropriate regulatory discussion and activities, including the filing of IND’s, CTXs, NDA/MAAs, throughout the development cycle
• Act as a clinical expert for both internal Company team members and external contacts related to the assigned therapeutic programs
• Provide clinical and scientific leadership including training and ongoing input, to members of the development and product core teams on issues related to the therapeutic field
• Establish and approve scientific methods for the design and implementation of applicable clinical protocols, data collection systems, and final reports
• Participate in the writing and review of clinical protocols, investigator brochures, clinical study reports, publications, and other documents
• Participate in clinical study report conceptualization, development and writing for global regulatory submissions